Children born to mothers using multiple drug therapy during their pregnancy

International Journal of Risk and Safety in Medicine

Volumn 8, Issue 3, 1996, Pages 237-241

  Merlob, Paul ^a,b   Stahl, Bracha ^a   Kaplan, Barry ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Drugs in pregnancy; Polytherapy; Teratogenic counselling; Teratology information service

Indexed keywords

ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG USE; FEMALE; FETUS MONITORING; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; NEWBORN; PATIENT COUNSELING; PREGNANCY; RISK ASSESSMENT; TERATOGENICITY; TREATMENT OUTCOME;

EID: 0029764692     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: 10.3233/jrs-1996-8307     Document Type: Article

References (4)

1. J.M. Garbis, E. Robert and P.W.J. Peters, Experience of two teratology information services in Europe, Teratology 42 (1990), 629-634.
2. C.R. King, Genetic counselling for teratogen exposure, Obstet. Gynecol. 67 (1986), 843-846.
3. P. Merlob, B. Stahl, A. Schoenfeld and B. Kaplan, Inadequate drug information for pregnant or lactating women: teratology information service follow-up, Risk and Safety Med. 6 (1995), 173-178.
4. M. Bonati, R. Bortolus, F. Marchetti, M. Romero and G. Tognoni, Drug use in pregnancy: an overview of epidemiological (drug utilization) studies, Eur. J. Clin. Pharmacol. 38 (1990), 325-328.